/Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer
Article

Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer

David I. QuinnMitchell E. GrossPulmonary and Respiratory MedicineMarch 3, 2020
Prostate Cancer and Prostatic Diseases
DOI:10.1038/s41391-020-0211-9Keywords:Phenelzine
Citation Map
The articles shown here are a subset.See the full list of articles below.

Citing (0)

Cited By (0)